Show Parent

April

In memoriam Romain Pauwels Bousquet J., Fabbri L., O'Byrne P., Van Cauwenberge P. Eur Respir J 2005; 25: 585-586
Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness? Sunyer J., Ulrik C. S. Eur Respir J 2005; 25: 587-588
Can inhaled steroids mend a broken heart in chronic obstructive pulmonary disease? Sin D. D., Man S. F. P. Eur Respir J 2005; 25: 589-590
Th1/Th2 paradigm: not seeing the forest for the trees? van Oosterhout A. J. M., Motta A. C. Eur Respir J 2005; 25: 591-593
Vascular endothelial growth factor in pleural effusions of different origin Sack U., Hoffmann M., Zhao X. J., Chan K. S., Hui D. S. C., Gosse H., Engelmann L., Schauer J., Emmrich F., Hoheisel G. Eur Respir J 2005; 25: 600-604
Interleukin-16 in tuberculous and malignant pleural effusions Qin X-J., Shi H-Z., Huang Z-X., Kang L-F., Mo W-N., Wu C. Eur Respir J 2005; 25: 605-611
Endothelial interactions of neutrophils under flow in chronic obstructive pulmonary disease Woolhouse I. S., Bayley D. L., Lalor P., Adams D. H., Stockley R. A. Eur Respir J 2005; 25: 612-617
Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males Stavem K., Aaser E., Sandvik L., Bjornholt J. V., Erikssen G., Thaulow E., Erikssen J. Eur Respir J 2005; 25: 618-625
Decrease of vascular endothelial growth factor in macrophages from long-term smokers Nagai K., Betsuyaku T., Ito Y., Nasuhara Y., Nishimura M. Eur Respir J 2005; 25: 626-633
Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD Huiart L., Ernst P., Ranouil X., Suissa S. Eur Respir J 2005; 25: 634-639
Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Fujimoto K., Yasuo M., Urushibata K., Hanaoka M., Koizumi T., Kubo K. Eur Respir J 2005; 25: 640-646
Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD Pons A. R., Noguera A., Blanquer D., Sauleda J., Pons J., Agusti A. G. N. Eur Respir J 2005; 25: 647-652
Adoptive transfer of T-helper cell type 1 clones attenuates an asthmatic phenotype in mice Irifune K., Yokoyama A., Sakai K., Watanabe A., Katayama H., Ohnishi H., Hamada H., Nakajima M., Kohno N., Higaki J. Eur Respir J 2005; 25: 653-659
The PREVASC study: the clinical effect of a multifaceted educational intervention to prevent childhood asthma Schonberger H. J. A. M., Dompeling E., Knottnerus J. A., Maas T., Muris J. W. M., van Weel C., van Schayck C. P. Eur Respir J 2005; 25: 660-670
Analysis of the cues used by patients when making assessments of their asthma severity Barley E. A., Jones P. W. Eur Respir J 2005; 25: 671-676
QT interval dispersion in obstructive sleep apnoea syndrome patients without hypertension Dursunoglu D., Dursunoglu N., Evrengul H., Ozkurt S., Kilic M., Fisekci F., Kuru O., Delen O. Eur Respir J 2005; 25: 677-681
Resting energy expenditure in Duchenne patients using home mechanical ventilation Gonzalez-Bermejo J., Lofaso F., Falaize L., Lejaille M., Raphael J-C., Similowski T., Melchior J-C. Eur Respir J 2005; 25: 682-687
Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia Schleicher G. K., Herbert V., Brink A., Martin S., Maraj R., Galpin J. S., Feldman C. Eur Respir J 2005; 25: 688-692
Relationship between the inoculum dose of Streptococcus pneumoniae and pneumonia onset in a rabbit model Yershov A. L., Jordan B. S., Guymon C. H., Dubick M. A. Eur Respir J 2005; 25: 693-700
CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis Capelli A., Di Stefano A., Gnemmi I., Donner C. F. Eur Respir J 2005; 25: 701-707
Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice Keogh K. A., Standing J., Kane G. C., Terzic A., Limper A. H. Eur Respir J 2005; 25: 708-714
New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis Mueller-Brandes C., Holl R. W., Nastoll M., Ballmann M. Eur Respir J 2005; 25: 715-717
Lung function in adults with cystic fibrosis at altitude: impact on air travel Fischer R., Lang S. M., Bruckner K., Hoyer H-X., Meyer S., Griese M., Huber R. M. Eur Respir J 2005; 25: 718-724
Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight Akero A., Christensen C. C., Edvardsen A., Skjonsberg O. H. Eur Respir J 2005; 25: 725-730
Asthma during pregnancy: mechanisms and treatment implications Murphy V. E., Gibson P. G., Smith R., Clifton V. L. Eur Respir J 2005; 25: 731-750
Should tuberculosis treatment and control be addressed differently in HIV-infected and -uninfected individuals? Dlodlo R. A., Fujiwara P. I., Enarson D. A. Eur Respir J 2005; 25: 751-757
Noninvasive assessment and monitoring of the pulmonary circulation Vonk-Noordegraaf A., van Wolferen S. A., Marcus J. T., Boonstra A., Postmus P. E., Peeters J. W. L., Peacock A. J. Eur Respir J 2005; 25: 758-766
A 75-year-old female with dyspnoea and chest pain Tresinie M., Van De Maele F., Verhaeghe W., Van de Maele B., Venken R., Hertveldt K. Eur Respir J 2005; 25: 768-770
Azithromycin in cystic fibrosis Kastelik J. A., Peckham D. G., Conway S. Eur Respir J 2005; 25: 771
From the authors Southern K. W., Barker P. M. Eur Respir J 2005; 25: 771-772
Value of imprint cytology for ultrasound-guided transthoracic core biopsy Paulose R. R., Shee C. D. Eur Respir J 2005; 25: 772
Flow limitation and dynamic hyperinflation Van Meerhaeghe A., Delpire P., Stenuit P., Kerkhofs M. Eur Respir J 2005; 25: 772
Assessments for oxygen therapy in COPD: are we under correcting arterial oxygen tensions? K. Dheda, K. Lim, B. Ollivere, J. Leftley, F.C. Lampe, A. Salisbury, J.P. Dilworth, R.K. Rajakulasingum. Eur Respir J 2005; 25: 773
Oxygen/nitrogen radicals. Lung injury and disease Hiemstra P.S. Eur Respir J 2005; 25: 774